RxDoctor Payments Data

Arun Rajan

Internal Medicine · Bethesda, MDNPI 1316111776

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $25 of the $39 with a category attached, or 63.9%. Novartis accounts for 63.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for internal medicine clinicians in MD, where the typical reported total is $161.

$39in general payments, 2019–2025

Across 2 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$25
  • Takeda Pharmaceuticals U.S.A., Inc.$14
$551,652in research payments, 2019–2025

Across 1 payment — averaging $551,652 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$552K

What the payments were for

  • Food & beverage$2564%
  • Education$1436%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$39 in reported general payments places this provider in the 30th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland

Other internal medicine in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →